Quest Diagnostics Inc.’s DGX second-quarter 2025 adjusted earnings per share (EPS) of $2.62 beat the Zacks Consensus Estimate by 1.9%. The metric also exceeded the year-ago adjusted figure by 11.5%.

These stocks were in great health last financial year. The post These 5 ASX 200 healthcare shares gained the most weight in FY25 appeared first on The Motley Fool Australia.

In 2024, 64% of the eligible-voting population turned out, the second highest in 120 years. New data show that even if all those voters who stayed home had voted, Trump would still be president today.

These graphics will guide you through science-based vaccine guidelines for children and adults ...